Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares, no par value per share
-
Shares outstanding
-
59,983,922
-
Total 13F shares
-
702,419
-
Share change
-
+536,623
-
Total reported value
-
$5,494,319
-
Price per share
-
$1.22
-
Number of holders
-
8
-
Value change
-
+$5,284,113
-
Number of buys
-
6
-
Number of sells
-
1
Institutional Holders of Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) as of Q3 2024
As of 30 Sep 2024,
Clearmind Medicine Inc. - Common Shares, no par value per share (CMND) was held by
8 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
702,419 shares.
The largest 8 holders included
Gotham Asset Management, LLC, AdvisorShares Investments LLC, UBS Group AG, Cornerstone Wealth Group, LLC, CITADEL ADVISORS LLC, HRT FINANCIAL LP, Royal Bank of Canada, and NATIONAL BANK OF CANADA /FI/.
This page lists
8
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.